Global Clinical Next Generation Sequencing (NGS) Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Clinical Next Generation Sequencing (NGS) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Clinical Next Generation Sequencing (NGS) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Clinical Next Generation Sequencing (NGS) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Clinical Next Generation Sequencing (NGS) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Clinical Next Generation Sequencing (NGS) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Clinical Next Generation Sequencing (NGS) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Clinical Next Generation Sequencing (NGS)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Clinical Next Generation Sequencing (NGS) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Illumina, Thermo Fisher Scientific, Eurofins Scientific and BGI Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Clinical Next Generation Sequencing (NGS) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Clinical Next Generation Sequencing (NGS) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Clinical Next Generation Sequencing (NGS), with revenue, gross margin and global market share of Clinical Next Generation Sequencing (NGS) from 2018 to 2023.
Chapter 3, the Clinical Next Generation Sequencing (NGS) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Clinical Next Generation Sequencing (NGS) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Clinical Next Generation Sequencing (NGS).
Chapter 13, to describe Clinical Next Generation Sequencing (NGS) research findings and conclusion.
This report is a detailed and comprehensive analysis for global Clinical Next Generation Sequencing (NGS) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Clinical Next Generation Sequencing (NGS) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Clinical Next Generation Sequencing (NGS) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Clinical Next Generation Sequencing (NGS) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Clinical Next Generation Sequencing (NGS) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Clinical Next Generation Sequencing (NGS)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Clinical Next Generation Sequencing (NGS) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Illumina, Thermo Fisher Scientific, Eurofins Scientific and BGI Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Clinical Next Generation Sequencing (NGS) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Sequencing by Synthesis (SBS)
- Nanopore Sequencing
- Single-Molecule Real-Time (SMRT) Sequencing
- Others
- Diagnostics
- Drug Discovery & Designing
- Medical Research
- Others
- Agilent Technologies
- Illumina
- Thermo Fisher Scientific
- Eurofins Scientific
- BGI Group
- Qiagen
- Roche Diagnostics
- Bio-Rad
- Congenica
- Theragen Etex
- PerkinElmer
- Partek
- Oxford Nanopore Technologies
- Pacific Biosciences of California
- Golden Helix
- BioDatomics
- PierianDx
- DNAStar
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Clinical Next Generation Sequencing (NGS) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Clinical Next Generation Sequencing (NGS), with revenue, gross margin and global market share of Clinical Next Generation Sequencing (NGS) from 2018 to 2023.
Chapter 3, the Clinical Next Generation Sequencing (NGS) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Clinical Next Generation Sequencing (NGS) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Clinical Next Generation Sequencing (NGS).
Chapter 13, to describe Clinical Next Generation Sequencing (NGS) research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Clinical Next Generation Sequencing (NGS)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Clinical Next Generation Sequencing (NGS) by Type
1.3.1 Overview: Global Clinical Next Generation Sequencing (NGS) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type in 2022
1.3.3 Sequencing by Synthesis (SBS)
1.3.4 Nanopore Sequencing
1.3.5 Single-Molecule Real-Time (SMRT) Sequencing
1.3.6 Others
1.4 Global Clinical Next Generation Sequencing (NGS) Market by Application
1.4.1 Overview: Global Clinical Next Generation Sequencing (NGS) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Diagnostics
1.4.3 Drug Discovery & Designing
1.4.4 Medical Research
1.4.5 Others
1.5 Global Clinical Next Generation Sequencing (NGS) Market Size & Forecast
1.6 Global Clinical Next Generation Sequencing (NGS) Market Size and Forecast by Region
1.6.1 Global Clinical Next Generation Sequencing (NGS) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Clinical Next Generation Sequencing (NGS) Market Size by Region, (2018-2029)
1.6.3 North America Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
1.6.4 Europe Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
1.6.6 South America Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Product and Solutions
2.1.4 Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 Illumina
2.2.1 Illumina Details
2.2.2 Illumina Major Business
2.2.3 Illumina Clinical Next Generation Sequencing (NGS) Product and Solutions
2.2.4 Illumina Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Illumina Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product and Solutions
2.3.4 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Eurofins Scientific
2.4.1 Eurofins Scientific Details
2.4.2 Eurofins Scientific Major Business
2.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product and Solutions
2.4.4 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Eurofins Scientific Recent Developments and Future Plans
2.5 BGI Group
2.5.1 BGI Group Details
2.5.2 BGI Group Major Business
2.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Product and Solutions
2.5.4 BGI Group Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 BGI Group Recent Developments and Future Plans
2.6 Qiagen
2.6.1 Qiagen Details
2.6.2 Qiagen Major Business
2.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Product and Solutions
2.6.4 Qiagen Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Qiagen Recent Developments and Future Plans
2.7 Roche Diagnostics
2.7.1 Roche Diagnostics Details
2.7.2 Roche Diagnostics Major Business
2.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product and Solutions
2.7.4 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Roche Diagnostics Recent Developments and Future Plans
2.8 Bio-Rad
2.8.1 Bio-Rad Details
2.8.2 Bio-Rad Major Business
2.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Product and Solutions
2.8.4 Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bio-Rad Recent Developments and Future Plans
2.9 Congenica
2.9.1 Congenica Details
2.9.2 Congenica Major Business
2.9.3 Congenica Clinical Next Generation Sequencing (NGS) Product and Solutions
2.9.4 Congenica Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Congenica Recent Developments and Future Plans
2.10 Theragen Etex
2.10.1 Theragen Etex Details
2.10.2 Theragen Etex Major Business
2.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Product and Solutions
2.10.4 Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Theragen Etex Recent Developments and Future Plans
2.11 PerkinElmer
2.11.1 PerkinElmer Details
2.11.2 PerkinElmer Major Business
2.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Product and Solutions
2.11.4 PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 PerkinElmer Recent Developments and Future Plans
2.12 Partek
2.12.1 Partek Details
2.12.2 Partek Major Business
2.12.3 Partek Clinical Next Generation Sequencing (NGS) Product and Solutions
2.12.4 Partek Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Partek Recent Developments and Future Plans
2.13 Oxford Nanopore Technologies
2.13.1 Oxford Nanopore Technologies Details
2.13.2 Oxford Nanopore Technologies Major Business
2.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product and Solutions
2.13.4 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Oxford Nanopore Technologies Recent Developments and Future Plans
2.14 Pacific Biosciences of California
2.14.1 Pacific Biosciences of California Details
2.14.2 Pacific Biosciences of California Major Business
2.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product and Solutions
2.14.4 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Pacific Biosciences of California Recent Developments and Future Plans
2.15 Golden Helix
2.15.1 Golden Helix Details
2.15.2 Golden Helix Major Business
2.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Product and Solutions
2.15.4 Golden Helix Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Golden Helix Recent Developments and Future Plans
2.16 BioDatomics
2.16.1 BioDatomics Details
2.16.2 BioDatomics Major Business
2.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Product and Solutions
2.16.4 BioDatomics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 BioDatomics Recent Developments and Future Plans
2.17 PierianDx
2.17.1 PierianDx Details
2.17.2 PierianDx Major Business
2.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Product and Solutions
2.17.4 PierianDx Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 PierianDx Recent Developments and Future Plans
2.18 DNAStar
2.18.1 DNAStar Details
2.18.2 DNAStar Major Business
2.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Product and Solutions
2.18.4 DNAStar Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 DNAStar Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Clinical Next Generation Sequencing (NGS) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Clinical Next Generation Sequencing (NGS) by Company Revenue
3.2.2 Top 3 Clinical Next Generation Sequencing (NGS) Players Market Share in 2022
3.2.3 Top 6 Clinical Next Generation Sequencing (NGS) Players Market Share in 2022
3.3 Clinical Next Generation Sequencing (NGS) Market: Overall Company Footprint Analysis
3.3.1 Clinical Next Generation Sequencing (NGS) Market: Region Footprint
3.3.2 Clinical Next Generation Sequencing (NGS) Market: Company Product Type Footprint
3.3.3 Clinical Next Generation Sequencing (NGS) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Clinical Next Generation Sequencing (NGS) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Clinical Next Generation Sequencing (NGS) Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2023)
5.2 Global Clinical Next Generation Sequencing (NGS) Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
6.2 North America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
6.3 North America Clinical Next Generation Sequencing (NGS) Market Size by Country
6.3.1 North America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2029)
6.3.2 United States Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
6.3.3 Canada Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
6.3.4 Mexico Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
7.2 Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
7.3 Europe Clinical Next Generation Sequencing (NGS) Market Size by Country
7.3.1 Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2029)
7.3.2 Germany Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
7.3.3 France Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
7.3.5 Russia Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
7.3.6 Italy Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Clinical Next Generation Sequencing (NGS) Market Size by Region
8.3.1 Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2018-2029)
8.3.2 China Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
8.3.3 Japan Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
8.3.4 South Korea Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
8.3.5 India Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
8.3.7 Australia Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
9.2 South America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
9.3 South America Clinical Next Generation Sequencing (NGS) Market Size by Country
9.3.1 South America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2029)
9.3.2 Brazil Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
9.3.3 Argentina Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Country
10.3.1 Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2029)
10.3.2 Turkey Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
10.3.4 UAE Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Clinical Next Generation Sequencing (NGS) Market Drivers
11.2 Clinical Next Generation Sequencing (NGS) Market Restraints
11.3 Clinical Next Generation Sequencing (NGS) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Clinical Next Generation Sequencing (NGS) Industry Chain
12.2 Clinical Next Generation Sequencing (NGS) Upstream Analysis
12.3 Clinical Next Generation Sequencing (NGS) Midstream Analysis
12.4 Clinical Next Generation Sequencing (NGS) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Clinical Next Generation Sequencing (NGS)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Clinical Next Generation Sequencing (NGS) by Type
1.3.1 Overview: Global Clinical Next Generation Sequencing (NGS) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type in 2022
1.3.3 Sequencing by Synthesis (SBS)
1.3.4 Nanopore Sequencing
1.3.5 Single-Molecule Real-Time (SMRT) Sequencing
1.3.6 Others
1.4 Global Clinical Next Generation Sequencing (NGS) Market by Application
1.4.1 Overview: Global Clinical Next Generation Sequencing (NGS) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Diagnostics
1.4.3 Drug Discovery & Designing
1.4.4 Medical Research
1.4.5 Others
1.5 Global Clinical Next Generation Sequencing (NGS) Market Size & Forecast
1.6 Global Clinical Next Generation Sequencing (NGS) Market Size and Forecast by Region
1.6.1 Global Clinical Next Generation Sequencing (NGS) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Clinical Next Generation Sequencing (NGS) Market Size by Region, (2018-2029)
1.6.3 North America Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
1.6.4 Europe Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
1.6.6 South America Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Clinical Next Generation Sequencing (NGS) Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Product and Solutions
2.1.4 Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 Illumina
2.2.1 Illumina Details
2.2.2 Illumina Major Business
2.2.3 Illumina Clinical Next Generation Sequencing (NGS) Product and Solutions
2.2.4 Illumina Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Illumina Recent Developments and Future Plans
2.3 Thermo Fisher Scientific
2.3.1 Thermo Fisher Scientific Details
2.3.2 Thermo Fisher Scientific Major Business
2.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product and Solutions
2.3.4 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.4 Eurofins Scientific
2.4.1 Eurofins Scientific Details
2.4.2 Eurofins Scientific Major Business
2.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product and Solutions
2.4.4 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Eurofins Scientific Recent Developments and Future Plans
2.5 BGI Group
2.5.1 BGI Group Details
2.5.2 BGI Group Major Business
2.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Product and Solutions
2.5.4 BGI Group Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 BGI Group Recent Developments and Future Plans
2.6 Qiagen
2.6.1 Qiagen Details
2.6.2 Qiagen Major Business
2.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Product and Solutions
2.6.4 Qiagen Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Qiagen Recent Developments and Future Plans
2.7 Roche Diagnostics
2.7.1 Roche Diagnostics Details
2.7.2 Roche Diagnostics Major Business
2.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product and Solutions
2.7.4 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Roche Diagnostics Recent Developments and Future Plans
2.8 Bio-Rad
2.8.1 Bio-Rad Details
2.8.2 Bio-Rad Major Business
2.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Product and Solutions
2.8.4 Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bio-Rad Recent Developments and Future Plans
2.9 Congenica
2.9.1 Congenica Details
2.9.2 Congenica Major Business
2.9.3 Congenica Clinical Next Generation Sequencing (NGS) Product and Solutions
2.9.4 Congenica Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Congenica Recent Developments and Future Plans
2.10 Theragen Etex
2.10.1 Theragen Etex Details
2.10.2 Theragen Etex Major Business
2.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Product and Solutions
2.10.4 Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Theragen Etex Recent Developments and Future Plans
2.11 PerkinElmer
2.11.1 PerkinElmer Details
2.11.2 PerkinElmer Major Business
2.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Product and Solutions
2.11.4 PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 PerkinElmer Recent Developments and Future Plans
2.12 Partek
2.12.1 Partek Details
2.12.2 Partek Major Business
2.12.3 Partek Clinical Next Generation Sequencing (NGS) Product and Solutions
2.12.4 Partek Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Partek Recent Developments and Future Plans
2.13 Oxford Nanopore Technologies
2.13.1 Oxford Nanopore Technologies Details
2.13.2 Oxford Nanopore Technologies Major Business
2.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product and Solutions
2.13.4 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Oxford Nanopore Technologies Recent Developments and Future Plans
2.14 Pacific Biosciences of California
2.14.1 Pacific Biosciences of California Details
2.14.2 Pacific Biosciences of California Major Business
2.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product and Solutions
2.14.4 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Pacific Biosciences of California Recent Developments and Future Plans
2.15 Golden Helix
2.15.1 Golden Helix Details
2.15.2 Golden Helix Major Business
2.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Product and Solutions
2.15.4 Golden Helix Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Golden Helix Recent Developments and Future Plans
2.16 BioDatomics
2.16.1 BioDatomics Details
2.16.2 BioDatomics Major Business
2.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Product and Solutions
2.16.4 BioDatomics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 BioDatomics Recent Developments and Future Plans
2.17 PierianDx
2.17.1 PierianDx Details
2.17.2 PierianDx Major Business
2.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Product and Solutions
2.17.4 PierianDx Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 PierianDx Recent Developments and Future Plans
2.18 DNAStar
2.18.1 DNAStar Details
2.18.2 DNAStar Major Business
2.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Product and Solutions
2.18.4 DNAStar Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 DNAStar Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Clinical Next Generation Sequencing (NGS) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Clinical Next Generation Sequencing (NGS) by Company Revenue
3.2.2 Top 3 Clinical Next Generation Sequencing (NGS) Players Market Share in 2022
3.2.3 Top 6 Clinical Next Generation Sequencing (NGS) Players Market Share in 2022
3.3 Clinical Next Generation Sequencing (NGS) Market: Overall Company Footprint Analysis
3.3.1 Clinical Next Generation Sequencing (NGS) Market: Region Footprint
3.3.2 Clinical Next Generation Sequencing (NGS) Market: Company Product Type Footprint
3.3.3 Clinical Next Generation Sequencing (NGS) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Clinical Next Generation Sequencing (NGS) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Clinical Next Generation Sequencing (NGS) Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2023)
5.2 Global Clinical Next Generation Sequencing (NGS) Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
6.2 North America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
6.3 North America Clinical Next Generation Sequencing (NGS) Market Size by Country
6.3.1 North America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2029)
6.3.2 United States Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
6.3.3 Canada Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
6.3.4 Mexico Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
7.2 Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
7.3 Europe Clinical Next Generation Sequencing (NGS) Market Size by Country
7.3.1 Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2029)
7.3.2 Germany Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
7.3.3 France Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
7.3.5 Russia Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
7.3.6 Italy Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Clinical Next Generation Sequencing (NGS) Market Size by Region
8.3.1 Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2018-2029)
8.3.2 China Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
8.3.3 Japan Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
8.3.4 South Korea Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
8.3.5 India Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
8.3.7 Australia Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
9.2 South America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
9.3 South America Clinical Next Generation Sequencing (NGS) Market Size by Country
9.3.1 South America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2029)
9.3.2 Brazil Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
9.3.3 Argentina Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Country
10.3.1 Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2029)
10.3.2 Turkey Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
10.3.4 UAE Clinical Next Generation Sequencing (NGS) Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Clinical Next Generation Sequencing (NGS) Market Drivers
11.2 Clinical Next Generation Sequencing (NGS) Market Restraints
11.3 Clinical Next Generation Sequencing (NGS) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Clinical Next Generation Sequencing (NGS) Industry Chain
12.2 Clinical Next Generation Sequencing (NGS) Upstream Analysis
12.3 Clinical Next Generation Sequencing (NGS) Midstream Analysis
12.4 Clinical Next Generation Sequencing (NGS) Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies Major Business
Table 7. Agilent Technologies Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 8. Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Agilent Technologies Recent Developments and Future Plans
Table 10. Illumina Company Information, Head Office, and Major Competitors
Table 11. Illumina Major Business
Table 12. Illumina Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 13. Illumina Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Illumina Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 18. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Thermo Fisher Scientific Recent Developments and Future Plans
Table 20. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 21. Eurofins Scientific Major Business
Table 22. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 23. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Eurofins Scientific Recent Developments and Future Plans
Table 25. BGI Group Company Information, Head Office, and Major Competitors
Table 26. BGI Group Major Business
Table 27. BGI Group Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 28. BGI Group Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. BGI Group Recent Developments and Future Plans
Table 30. Qiagen Company Information, Head Office, and Major Competitors
Table 31. Qiagen Major Business
Table 32. Qiagen Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 33. Qiagen Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Qiagen Recent Developments and Future Plans
Table 35. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 36. Roche Diagnostics Major Business
Table 37. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 38. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Roche Diagnostics Recent Developments and Future Plans
Table 40. Bio-Rad Company Information, Head Office, and Major Competitors
Table 41. Bio-Rad Major Business
Table 42. Bio-Rad Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 43. Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Bio-Rad Recent Developments and Future Plans
Table 45. Congenica Company Information, Head Office, and Major Competitors
Table 46. Congenica Major Business
Table 47. Congenica Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 48. Congenica Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Congenica Recent Developments and Future Plans
Table 50. Theragen Etex Company Information, Head Office, and Major Competitors
Table 51. Theragen Etex Major Business
Table 52. Theragen Etex Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 53. Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Theragen Etex Recent Developments and Future Plans
Table 55. PerkinElmer Company Information, Head Office, and Major Competitors
Table 56. PerkinElmer Major Business
Table 57. PerkinElmer Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 58. PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. PerkinElmer Recent Developments and Future Plans
Table 60. Partek Company Information, Head Office, and Major Competitors
Table 61. Partek Major Business
Table 62. Partek Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 63. Partek Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Partek Recent Developments and Future Plans
Table 65. Oxford Nanopore Technologies Company Information, Head Office, and Major Competitors
Table 66. Oxford Nanopore Technologies Major Business
Table 67. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 68. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Oxford Nanopore Technologies Recent Developments and Future Plans
Table 70. Pacific Biosciences of California Company Information, Head Office, and Major Competitors
Table 71. Pacific Biosciences of California Major Business
Table 72. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 73. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Pacific Biosciences of California Recent Developments and Future Plans
Table 75. Golden Helix Company Information, Head Office, and Major Competitors
Table 76. Golden Helix Major Business
Table 77. Golden Helix Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 78. Golden Helix Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Golden Helix Recent Developments and Future Plans
Table 80. BioDatomics Company Information, Head Office, and Major Competitors
Table 81. BioDatomics Major Business
Table 82. BioDatomics Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 83. BioDatomics Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. BioDatomics Recent Developments and Future Plans
Table 85. PierianDx Company Information, Head Office, and Major Competitors
Table 86. PierianDx Major Business
Table 87. PierianDx Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 88. PierianDx Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. PierianDx Recent Developments and Future Plans
Table 90. DNAStar Company Information, Head Office, and Major Competitors
Table 91. DNAStar Major Business
Table 92. DNAStar Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 93. DNAStar Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. DNAStar Recent Developments and Future Plans
Table 95. Global Clinical Next Generation Sequencing (NGS) Revenue (USD Million) by Players (2018-2023)
Table 96. Global Clinical Next Generation Sequencing (NGS) Revenue Share by Players (2018-2023)
Table 97. Breakdown of Clinical Next Generation Sequencing (NGS) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Clinical Next Generation Sequencing (NGS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Clinical Next Generation Sequencing (NGS) Players
Table 100. Clinical Next Generation Sequencing (NGS) Market: Company Product Type Footprint
Table 101. Clinical Next Generation Sequencing (NGS) Market: Company Product Application Footprint
Table 102. Clinical Next Generation Sequencing (NGS) New Market Entrants and Barriers to Market Entry
Table 103. Clinical Next Generation Sequencing (NGS) Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Clinical Next Generation Sequencing (NGS) Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global Clinical Next Generation Sequencing (NGS) Consumption Value Share by Type (2018-2023)
Table 106. Global Clinical Next Generation Sequencing (NGS) Consumption Value Forecast by Type (2024-2029)
Table 107. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2023)
Table 108. Global Clinical Next Generation Sequencing (NGS) Consumption Value Forecast by Application (2024-2029)
Table 109. North America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Clinical Next Generation Sequencing (NGS) Raw Material
Table 140. Key Suppliers of Clinical Next Generation Sequencing (NGS) Raw Materials
Table 1. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies Major Business
Table 7. Agilent Technologies Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 8. Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Agilent Technologies Recent Developments and Future Plans
Table 10. Illumina Company Information, Head Office, and Major Competitors
Table 11. Illumina Major Business
Table 12. Illumina Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 13. Illumina Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Illumina Recent Developments and Future Plans
Table 15. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 18. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Thermo Fisher Scientific Recent Developments and Future Plans
Table 20. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 21. Eurofins Scientific Major Business
Table 22. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 23. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Eurofins Scientific Recent Developments and Future Plans
Table 25. BGI Group Company Information, Head Office, and Major Competitors
Table 26. BGI Group Major Business
Table 27. BGI Group Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 28. BGI Group Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. BGI Group Recent Developments and Future Plans
Table 30. Qiagen Company Information, Head Office, and Major Competitors
Table 31. Qiagen Major Business
Table 32. Qiagen Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 33. Qiagen Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Qiagen Recent Developments and Future Plans
Table 35. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 36. Roche Diagnostics Major Business
Table 37. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 38. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Roche Diagnostics Recent Developments and Future Plans
Table 40. Bio-Rad Company Information, Head Office, and Major Competitors
Table 41. Bio-Rad Major Business
Table 42. Bio-Rad Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 43. Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Bio-Rad Recent Developments and Future Plans
Table 45. Congenica Company Information, Head Office, and Major Competitors
Table 46. Congenica Major Business
Table 47. Congenica Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 48. Congenica Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Congenica Recent Developments and Future Plans
Table 50. Theragen Etex Company Information, Head Office, and Major Competitors
Table 51. Theragen Etex Major Business
Table 52. Theragen Etex Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 53. Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Theragen Etex Recent Developments and Future Plans
Table 55. PerkinElmer Company Information, Head Office, and Major Competitors
Table 56. PerkinElmer Major Business
Table 57. PerkinElmer Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 58. PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. PerkinElmer Recent Developments and Future Plans
Table 60. Partek Company Information, Head Office, and Major Competitors
Table 61. Partek Major Business
Table 62. Partek Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 63. Partek Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Partek Recent Developments and Future Plans
Table 65. Oxford Nanopore Technologies Company Information, Head Office, and Major Competitors
Table 66. Oxford Nanopore Technologies Major Business
Table 67. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 68. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Oxford Nanopore Technologies Recent Developments and Future Plans
Table 70. Pacific Biosciences of California Company Information, Head Office, and Major Competitors
Table 71. Pacific Biosciences of California Major Business
Table 72. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 73. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Pacific Biosciences of California Recent Developments and Future Plans
Table 75. Golden Helix Company Information, Head Office, and Major Competitors
Table 76. Golden Helix Major Business
Table 77. Golden Helix Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 78. Golden Helix Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Golden Helix Recent Developments and Future Plans
Table 80. BioDatomics Company Information, Head Office, and Major Competitors
Table 81. BioDatomics Major Business
Table 82. BioDatomics Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 83. BioDatomics Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. BioDatomics Recent Developments and Future Plans
Table 85. PierianDx Company Information, Head Office, and Major Competitors
Table 86. PierianDx Major Business
Table 87. PierianDx Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 88. PierianDx Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. PierianDx Recent Developments and Future Plans
Table 90. DNAStar Company Information, Head Office, and Major Competitors
Table 91. DNAStar Major Business
Table 92. DNAStar Clinical Next Generation Sequencing (NGS) Product and Solutions
Table 93. DNAStar Clinical Next Generation Sequencing (NGS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. DNAStar Recent Developments and Future Plans
Table 95. Global Clinical Next Generation Sequencing (NGS) Revenue (USD Million) by Players (2018-2023)
Table 96. Global Clinical Next Generation Sequencing (NGS) Revenue Share by Players (2018-2023)
Table 97. Breakdown of Clinical Next Generation Sequencing (NGS) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Clinical Next Generation Sequencing (NGS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Clinical Next Generation Sequencing (NGS) Players
Table 100. Clinical Next Generation Sequencing (NGS) Market: Company Product Type Footprint
Table 101. Clinical Next Generation Sequencing (NGS) Market: Company Product Application Footprint
Table 102. Clinical Next Generation Sequencing (NGS) New Market Entrants and Barriers to Market Entry
Table 103. Clinical Next Generation Sequencing (NGS) Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Clinical Next Generation Sequencing (NGS) Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global Clinical Next Generation Sequencing (NGS) Consumption Value Share by Type (2018-2023)
Table 106. Global Clinical Next Generation Sequencing (NGS) Consumption Value Forecast by Type (2024-2029)
Table 107. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2023)
Table 108. Global Clinical Next Generation Sequencing (NGS) Consumption Value Forecast by Application (2024-2029)
Table 109. North America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Clinical Next Generation Sequencing (NGS) Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Clinical Next Generation Sequencing (NGS) Raw Material
Table 140. Key Suppliers of Clinical Next Generation Sequencing (NGS) Raw Materials
LIST OF FIGURES
Figure 1. Clinical Next Generation Sequencing (NGS) Picture
Figure 2. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type in 2022
Figure 4. Sequencing by Synthesis (SBS)
Figure 5. Nanopore Sequencing
Figure 6. Single-Molecule Real-Time (SMRT) Sequencing
Figure 7. Others
Figure 8. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application in 2022
Figure 10. Diagnostics Picture
Figure 11. Drug Discovery & Designing Picture
Figure 12. Medical Research Picture
Figure 13. Others Picture
Figure 14. Global Clinical Next Generation Sequencing (NGS) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Clinical Next Generation Sequencing (NGS) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Clinical Next Generation Sequencing (NGS) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Region in 2022
Figure 19. North America Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Clinical Next Generation Sequencing (NGS) Revenue Share by Players in 2022
Figure 25. Clinical Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Clinical Next Generation Sequencing (NGS) Market Share in 2022
Figure 27. Global Top 6 Players Clinical Next Generation Sequencing (NGS) Market Share in 2022
Figure 28. Global Clinical Next Generation Sequencing (NGS) Consumption Value Share by Type (2018-2023)
Figure 29. Global Clinical Next Generation Sequencing (NGS) Market Share Forecast by Type (2024-2029)
Figure 30. Global Clinical Next Generation Sequencing (NGS) Consumption Value Share by Application (2018-2023)
Figure 31. Global Clinical Next Generation Sequencing (NGS) Market Share Forecast by Application (2024-2029)
Figure 32. North America Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 42. France Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Region (2018-2029)
Figure 49. China Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 52. India Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 66. Clinical Next Generation Sequencing (NGS) Market Drivers
Figure 67. Clinical Next Generation Sequencing (NGS) Market Restraints
Figure 68. Clinical Next Generation Sequencing (NGS) Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Clinical Next Generation Sequencing (NGS) in 2022
Figure 71. Manufacturing Process Analysis of Clinical Next Generation Sequencing (NGS)
Figure 72. Clinical Next Generation Sequencing (NGS) Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Clinical Next Generation Sequencing (NGS) Picture
Figure 2. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type in 2022
Figure 4. Sequencing by Synthesis (SBS)
Figure 5. Nanopore Sequencing
Figure 6. Single-Molecule Real-Time (SMRT) Sequencing
Figure 7. Others
Figure 8. Global Clinical Next Generation Sequencing (NGS) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application in 2022
Figure 10. Diagnostics Picture
Figure 11. Drug Discovery & Designing Picture
Figure 12. Medical Research Picture
Figure 13. Others Picture
Figure 14. Global Clinical Next Generation Sequencing (NGS) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Clinical Next Generation Sequencing (NGS) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Clinical Next Generation Sequencing (NGS) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Region in 2022
Figure 19. North America Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Clinical Next Generation Sequencing (NGS) Revenue Share by Players in 2022
Figure 25. Clinical Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Clinical Next Generation Sequencing (NGS) Market Share in 2022
Figure 27. Global Top 6 Players Clinical Next Generation Sequencing (NGS) Market Share in 2022
Figure 28. Global Clinical Next Generation Sequencing (NGS) Consumption Value Share by Type (2018-2023)
Figure 29. Global Clinical Next Generation Sequencing (NGS) Market Share Forecast by Type (2024-2029)
Figure 30. Global Clinical Next Generation Sequencing (NGS) Consumption Value Share by Application (2018-2023)
Figure 31. Global Clinical Next Generation Sequencing (NGS) Market Share Forecast by Application (2024-2029)
Figure 32. North America Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 42. France Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Region (2018-2029)
Figure 49. China Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 52. India Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Clinical Next Generation Sequencing (NGS) Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Clinical Next Generation Sequencing (NGS) Consumption Value (2018-2029) & (USD Million)
Figure 66. Clinical Next Generation Sequencing (NGS) Market Drivers
Figure 67. Clinical Next Generation Sequencing (NGS) Market Restraints
Figure 68. Clinical Next Generation Sequencing (NGS) Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Clinical Next Generation Sequencing (NGS) in 2022
Figure 71. Manufacturing Process Analysis of Clinical Next Generation Sequencing (NGS)
Figure 72. Clinical Next Generation Sequencing (NGS) Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
